SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001558370-24-012577 from ProMIS Neurosciences Inc. (PMN)

ProMIS Neurosciences Inc.
Date: Sept. 4, 2024 · CIK: 0001374339 · Accession: 0001558370-24-012577

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-281841

Date
September 4, 2024
Author
Form
CORRESP
Company
ProMIS Neurosciences Inc.

Letter

Re:

VIA EDGAR

September 4, 2024

United States Securities and Exchange Commission Division of Corporation Finance

100 F Street, N.E. Washington, D.C. 20549

ProMIS Neurosciences Inc.

Acceleration Request for Registration Statement on Form S-3

File No. 333-281841

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), ProMIS Neurosciences Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to September 6, 2024, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Adam V. Johnson at (212) 459-7072. If you have any questions regarding this request, please contact Adam V. Johnson of Goodwin Procter LLP at (212) 459-7072.

Sincerely,

Show Raw Text
CORRESP
1
filename1.htm

VIA EDGAR

​

September 4, 2024

​

United States Securities and Exchange Commission
Division of Corporation Finance

100 F Street, N.E.
Washington, D.C. 20549

​

Re:

 ProMIS Neurosciences Inc.

​

 Acceleration Request for Registration Statement on Form S-3

​

 File No. 333-281841

​

Ladies and Gentlemen:

​

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), ProMIS Neurosciences Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to September 6, 2024, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

​

Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling Adam V. Johnson at (212) 459-7072. If you have any questions regarding this request, please contact Adam V. Johnson of Goodwin Procter LLP at (212) 459-7072.

​

​

 ​

 ​

​

 Sincerely,

​

 ​

​

 PROMIS NEUROSCIENCES INC.

​

 ​

​

 /s/ Neil Warma

​

 Neil Warma

​

 Interim Chief Executive Officer

​

 ​

cc:

 Adam V. Johnson, Goodwin Procter LLP

 ​

​